Using 18F-FAPI PET to Detect Metastatic Disease in Patients That Have Gastric or Esophageal Cancer
Phase 3
200
about 1.8 years
18+
10 sites in CA, FL, IN +3
What this study is about
Researchers are testing whether a new imaging test, called 18F-FAPI PET/CT, can help find cancer that has spread (metastasis) in people with gastric or esophageal cancer. The trial will involve using this imaging test to see if it accurately detects metastatic disease.
Simplified from trial records by PatientMatch.
What you may be asked to do
- 1.Take [18F]FAPI-74 PET/CT
Participation Burden
What's physically and logistically required of participants.
Requires travel to a study site
How treatment is administered
Everyone gets the investigational treatment.
Extracted study details
Pulled from the trial record to show what is being tested and what the study is measuring.
Secondary: Incidence and severity of adverse events using CTCAE v5., Number of participants with treatment-related adverse events as assessed by blood pressure changes, Number of participants with treatment-related adverse events as assessed by body temperature changes, Number of participants with treatment-related adverse events as assessed by pulse rate, Number of participants with treatment-related adverse events as assessed by respiration rate